Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
Hellmann, Matthew D, Ciuleanu, Tudor-Eliade, Pluzanski, Adam, Lee, Jong Seok, Otterson, Gregory A, Audigier-Valette, Clarisse, Minenza, Elisa, Linardou, Helena, Burgers, Sjaak, Salman, Pamela, Borghaei, Hossein, Ramalingam, Suresh S, Brahmer, Julie, Reck, Martin, O’Byrne, Kenneth J, Geese, William J, Green, George, Chang, Han, Szustakowski, Joseph, Bhagavatheeswaran, Prabhu, Healey, Diane, Fu, Yali, Nathan, Faith, Paz-Ares, Luis
Published in The New England journal of medicine (31.05.2018)
Published in The New England journal of medicine (31.05.2018)
Get full text
Journal Article
Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study
Tabernero, J., Hozak, R.R., Yoshino, T., Cohn, A.L., Obermannova, R., Bodoky, G., Garcia-Carbonero, R., Ciuleanu, T.-E., Portnoy, D.C., Prausová, J., Muro, K., Siegel, R.W., Konrad, R.J., Ouyang, H., Melemed, S.A., Ferry, D., Nasroulah, F., Van Cutsem, E.
Published in Annals of oncology (01.03.2018)
Published in Annals of oncology (01.03.2018)
Get full text
Journal Article
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update
Reck, M., Ciuleanu, T.-E., Cobo, M., Schenker, M., Zurawski, B., Menezes, J., Richardet, E., Bennouna, J., Felip, E., Juan-Vidal, O., Alexandru, A., Sakai, H., Lingua, A., Reyes, F., Souquet, P.-J., De Marchi, P., Martin, C., Pérol, M., Scherpereel, A., Lu, S., Paz-Ares, L., Carbone, D.P., Memaj, A., Marimuthu, S., Zhang, X., Tran, P., John, T.
Published in ESMO open (01.10.2021)
Published in ESMO open (01.10.2021)
Get full text
Journal Article
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Thatcher, Nick, Prof, Hirsch, Fred R, Prof, Luft, Alexander V, MD, Szczesna, Aleksandra, MD, Ciuleanu, Tudor E, Prof, Dediu, Mircea, MD, Ramlau, Rodryg, Prof, Galiulin, Rinat K, MD, Bálint, Beatrix, MD, Losonczy, György, Prof, Kazarnowicz, Andrzej, MD, Park, Keunchil, MD, Schumann, Christian, Prof, Reck, Martin, MD, Depenbrock, Henrik, MD, Nanda, Shivani, MS, Kruljac-Letunic, Anamarija, PhD, Kurek, Raffael, MD, Paz-Ares, Luis, MD, Socinski, Mark A, Prof
Published in The lancet oncology (01.07.2015)
Published in The lancet oncology (01.07.2015)
Get full text
Journal Article
Web Resource
Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis
Borghaei, H., Ciuleanu, T.-E., Lee, J.-S., Pluzanski, A., Caro, R. Bernabe, Gutierrez, M., Ohe, Y., Nishio, M., Goldman, J., Ready, N., Spigel, D.R., Ramalingam, S.S., Paz-Ares, L.G., Gainor, J.F., Ahmed, S., Reck, M., Maio, M., O’Byrne, K.J., Memaj, A., Nathan, F., Tran, P., Hellmann, M.D., Brahmer, J.R.
Published in Annals of oncology (01.02.2023)
Published in Annals of oncology (01.02.2023)
Get full text
Journal Article
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation
Fountzilas, G., Ciuleanu, E., Bobos, M., Kalogera-Fountzila, A., Eleftheraki, A.G., Karayannopoulou, G., Zaramboukas, T., Nikolaou, A., Markou, K., Resiga, L., Dionysopoulos, D., Samantas, E., Athanassiou, H., Misailidou, D., Skarlos, D., Ciuleanu, T.
Published in Annals of oncology (01.02.2012)
Published in Annals of oncology (01.02.2012)
Get full text
Journal Article
Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer
Peeters, M., Price, T.J., Cervantes, A., Sobrero, A.F., Ducreux, M., Hotko, Y., André, T., Chan, E., Lordick, F., Punt, C.J.A., Strickland, A.H., Wilson, G., Ciuleanu, T.E., Roman, L., Van Cutsem, E., Tian, Y., Sidhu, R.
Published in Annals of oncology (01.01.2014)
Published in Annals of oncology (01.01.2014)
Get full text
Journal Article
Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
SMITH, Robert E, AAPRO, Matti S, LUDWIG, Heinz, PINTER, Tamds, SMAKAL, Martin, CIULEANU, Tudor E, LI CHEN, LILLIE, Tom, GLASPY, John A
Published in Journal of clinical oncology (01.03.2008)
Published in Journal of clinical oncology (01.03.2008)
Get full text
Journal Article
FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study
Brodowicz, T., Ciuleanu, T.E., Radosavljevic, D., Shacham-Shmueli, E., Vrbanec, D., Plate, S., Mrsic-Krmpotic, Z., Dank, M., Purkalne, G., Messinger, D., Zielinski, C.C.
Published in Annals of oncology (01.07.2013)
Published in Annals of oncology (01.07.2013)
Get full text
Journal Article
Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT)
Janžič, Urška, Turnšek, Nina, Dediu, Mircea, Donev, Ivan Shterev, Lupu, Roxana, Teodorescu, Gabriela, Ciuleanu, Tudor E, Pluzanski, Adam
Published in Current oncology (Toronto) (01.08.2022)
Published in Current oncology (Toronto) (01.08.2022)
Get full text
Journal Article
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors
Fizazi, Karim, Drake, Charles G., Beer, Tomasz M., Kwon, Eugene D., Scher, Howard I., Gerritsen, Winald R., Bossi, Alberto, den Eertwegh, Alfons J.M. van, Krainer, Michael, Houede, Nadine, Santos, Ricardo, Mahammedi, Hakim, Ng, Siobhan, Danielli, Riccardo, Franke, Fabio A., Sundar, Santhanam, Agarwal, Neeraj, Bergman, André M., Ciuleanu, Tudor E., Korbenfeld, Ernesto, Sengeløv, Lisa, Hansen, Steinbjorn, McHenry, M. Brent, Chen, Allen, Logothetis, Christopher
Published in European urology (01.12.2020)
Published in European urology (01.12.2020)
Get full text
Journal Article
Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial
Ocvirk, Janja, Brodowicz, Thomas, Wrba, Fritz, Ciuleanu, Tudor E, Kurteva, Galina, Beslija, Semir, Koza, Ivan, Pápai, Zsuzsanna, Messinger, Diethelm, Yilmaz, Ugur, Faluhelyi, Zsolt, Yalcin, Suayib, Papamichael, Demetris, Wenczl, Miklós, Mrsic-Krmpotic, Zrinka, Shacham-Shmueli, Einat, Vrbanec, Damir, Esser, Regina, Scheithauer, Werner, Zielinski, Christoph C
Published in World journal of gastroenterology : WJG (07.07.2010)
Published in World journal of gastroenterology : WJG (07.07.2010)
Get full text
Journal Article
Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial
Borghaei, H, O'Byrne, K J, Paz-Ares, L, Ciuleanu, T-E, Yu, X, Pluzanski, A, Nagrial, A, Havel, L, Kowalyszyn, R D, Valette, C A, Brahmer, J R, Reck, M, Ramalingam, S S, Zhang, L, Ntambwe, I, Rabindran, S K, Nathan, F E, Balli, D, Wu, Y-L
Published in ESMO open (01.12.2023)
Published in ESMO open (01.12.2023)
Get full text
Journal Article
Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study
Belani, Chandra P, Prof, Brodowicz, Thomas, MD, Ciuleanu, Tudor E, MD, Krzakowski, Maciej, Prof, Yang, Sung Hyun, MD, Franke, Fábio, MD, Cucevic, Branka, MD, Madhavan, Jayaprakash, MD, Santoro, Armando, MD, Ramlau, Rodryg, MD, Liepa, Astra M, PharmD, Visseren-Grul, Carla, MD, Peterson, Patrick, PhD, John, William J, MD, Zielinski, Christoph C, Prof
Published in The lancet oncology (01.03.2012)
Published in The lancet oncology (01.03.2012)
Get full text
Journal Article
Mutation profiles of nasopharyngeal carcinomas in South-Eastern European patients
Fountzilas, G., Psyrri, A., Giannoulatou, E., Kouvatseas, G., Rontogianni, D., Ciuleanu, E., Ciuleanu, T.-E., Resiga, L., Zaramboukas, T., Bobos, M., Chrisafi, S., Tsolaki, E., Papadopoulou, K., Markou, K., Charalambakis, N., Koutras, A., Kalogera-Fountzila, A., Skondra, M., Pectasides, D., Kotoula, V.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer
Del Campo, J. M., Roszak, A., Bidzinski, M., Ciuleanu, T. E., Hogberg, T., Wojtukiewicz, M. Z., Poveda, A., Boman, K., Westermann, A. M., Lebedinsky, C.
Published in Annals of oncology (01.11.2009)
Published in Annals of oncology (01.11.2009)
Get full text
Journal Article
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial
Camerini, A., Morabito, A., Montanino, A., Bernabé, R., Grossi, F., Ramlau, R., Ciuleanu, T.-E., Ceresoli, G.-L., Pasello, G., de Marinis, F., Bosch-Barrera, J., Laundreau, P., Gautier, S., Ta Thanh Minh, C., Kowalski, D.
Published in ESMO open (01.04.2021)
Published in ESMO open (01.04.2021)
Get full text
Journal Article
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study
Ferris, R.L., Haddad, R., Even, C., Tahara, M., Dvorkin, M., Ciuleanu, T.E., Clement, P.M., Mesia, R., Kutukova, S., Zholudeva, L., Daste, A., Caballero-Daroqui, J., Keam, B., Vynnychenko, I., Lafond, C., Shetty, J., Mann, H., Fan, J., Wildsmith, S., Morsli, N., Fayette, J., Licitra, L.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
Carbone, David P, Reck, Martin, Paz-Ares, Luis, Creelan, Benjamin, Horn, Leora, Steins, Martin, Felip, Enriqueta, van den Heuvel, Michel M, Ciuleanu, Tudor-Eliade, Badin, Firas, Ready, Neal, Hiltermann, T. Jeroen N, Nair, Suresh, Juergens, Rosalyn, Peters, Solange, Minenza, Elisa, Wrangle, John M, Rodriguez-Abreu, Delvys, Borghaei, Hossein, Blumenschein, George R, Villaruz, Liza C, Havel, Libor, Krejci, Jana, Corral Jaime, Jesus, Chang, Han, Geese, William J, Bhagavatheeswaran, Prabhu, Chen, Allen C, Socinski, Mark A
Published in The New England journal of medicine (22.06.2017)
Published in The New England journal of medicine (22.06.2017)
Get full text
Journal Article
Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331
Spigel, D.R., Vicente, D., Ciuleanu, T.E., Gettinger, S., Peters, S., Horn, L., Audigier-Valette, C., Pardo Aranda, N., Juan-Vidal, O., Cheng, Y., Zhang, H., Shi, M., Luft, A., Wolf, J., Antonia, S., Nakagawa, K., Fairchild, J., Baudelet, C., Pandya, D., Doshi, P., Chang, H., Reck, M.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article